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I 
n  addition to their essential role in presenting pathogen 
peptides for recognition by the antigen receptor of killer 
CD8 T  cells,  MHC class I molecules can be the targets of 
another fundamentally different mode of recognition,  also 
involved in fighting pathogens. Studies  on NK, a compo- 
nent of the innate immune system that comes into action at 
the  early phase of many intracellular  infections,  have un- 
covered an entire set of new receptors for MHC class I that 
are encoded in the so-called NK gene complex (NKC;  1), 
and have provided support for the idea that NK cells survey 
for the absence of self-MHC molecules (2)  through these 
receptors  (3).  This  function  is  crucial  for fighting against 
certain  viruses,  such  as  herpes viruses  (4-6).  The  current 
challenge that is addressed in this issue of The Journal of Ex- 
perimental Medicine by Johansson et al.,  is to understand the 
rules for selection and tolerance of NK cells expressing ap- 
propriate MHC-specific receptors in the face of the poly- 
morphism of inherited MHC genes. 
MHC-specific  NK Receptors and the Recognition of Missing 
Self,  MHC-specific NKRs are  encoded by genes in  the 
NK complex. They belong to at least two different struc- 
tural families,  one with Ig domains and the other with a car- 
bohydrate recognition domain,  that are both represented, 
albeit to variable degrees, in mice and humans  (7-9). Un- 
like TCKs, NKRs do not discriminate between most MHC- 
peptide complexes, despite the fact that recognition is cen- 
tered around the peptide-binding groove and depends upon 
peptide-induced  conformation of the  MHC  molecule.  In 
that regard,  NKR  recognition of MHC is very similar to 
that  of antibodies  against  the  otl/c~2  domains  of MHC. 
They  recognize  allelic  forms  of MHC  molecules,  often 
cross-reacting  onto  several  other  MHC  allotypes  or  iso- 
types. 
A  biochemical  characteristic  of  many  MHC-specific 
NKRs  is  the  presence  of an  immunoreceptor  tyrosine- 
based inhibitory motif in the cytoplasmic tail,  which binds 
and activates the tyrosine phosphatase SHP-1  upon phos- 
phorylation. Thus, normal, uninfected cells engage MHC- 
specific NKRs and deactivate NK cells by preventing phos- 
phorylation-dependent  cell  activation transduced  through 
activating NK receptors such  as NKI.1  (10,  11).  In con- 
trast, downmodulation of MHC class I, a strategy of escape 
from CD8 killer cells attempted by many viruses, is coun- 
tered by NK cell-mediated kilhng. 
Coevolution of  MI-IC and NKC Genes.  Unlike TCR genes, 
NKR  genes  do not  undergo  somatic recombination,  and 
the number ofMHC-specific NKR. genes is limited, in the 
range of 15-30 in mice and humans, with a degree ofpoly- 
morphism that is low compared to that of MHC. Therefore, 
evolutionary considerations suggest that the primary pres- 
sure for diversification has driven the MHC genes, whereas 
NKR genes, which are encoded in a separate locus, had to 
coevolve in  an  evolutionary pursuit  to  match  the  arising 
new MHC alleles. 
To fulfill their function of MHC surveillance at the level 
of the individual, NK cells must therefore tailor the use of 
their MHC-specific NKRs  to  the  inherited  set  of MHC 
genes through some process of selection or adaptation. Be- 
cause  the  MHC  and  the  NKC  are  encoded  on  different 
chromosomes, and because the selection pressures for par- 
ticular MHC and NKR genes may be different, exerted by 
different pathogens at different times or in different popula- 
tions, it may not always be possible to select a perfect NK_R 
repertoire.  For  example,  some  MHC  alleles  may not  be 
recognized by existing NKRs, or on the contrary, they may 
be recognized with  too  high  an  affinity by some NK_Iks. 
Some individuals may therefore inherit largely incompati- 
ble sets of alleles,  with NKKs that are unable to see MHC 
or that  are  insensitive  to  its  downmodulation  by viruses. 
Such theoretical situations could account for the existence 
of human patients (4) or mouse strains,  such as SJL (12)  or 
nonobese diabetic (13), that are profoundly deficient in NK 
function. 
The Regulation of MHC-specific NKR Expression.  These 
evolutionary  considerations  emphasize  the  complexity of 
matching  the  expression  of NKR  genes  with  the  MHC 
genes inherited by the individual. Within the framework of 
the missing-self hypothesis (14),  a functional NK must ex- 
press one or more NKtks that bind host MHC alleles with 
sufficient combined  avidity to  prevent  autoreactivity  (self 
tolerance). This avidity should not be too high however, or 
the NK would be unable to detect significant decreases in 
MHC expression. 
What controls the expression of NKR genes? A key ob- 
servation is that subsets of NK can be defined by the  ex- 
pression  of different MHC-specific NKRs  (15).  The fre- 
quency of NK expressing a particular MHC-specific NKR 
does not vary much according to the MHC haplotype. For 
example, B6  (H2  b) NK cells  express the Dd-specific NKR 
Ly49A, a member of the Ly49 family of NKtk genes, with 
the same frequency (15-20%) as NK cells in B10.D2 (H2  a) 
mice. Thus, NK cells seem to express useful, as well as pre- 
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observation  is  that  the  frequency  of NK cells  expressing 
two  different NKILs of the  Ly49  family is  close  to  what 
would  be expected in  a  purely stochastic  model of Ly49 
gene activation, i.e., the product of the frequency of single 
expressors,  suggesting  that  different  genes  and  alleles  are 
randomly  activated  at  a  low  frequency.  These  results 
strongly support the idea that stochastic activation of Ly49 
genes contributes the primary NKR repertoire (16,  17). 
Since little bias is observed in the frequency ofLy49 iso- 
type expression by NK cells  of different MHC genotypes, 
the possibility exists that NK cells expressing inappropriate 
MHC-specific NKRs may not be deleted.  It could be ar- 
gued that because not all NKR. specificities are known yet, 
it is not possible to rule out deletion-based selection as the 
main process for forging an appropriate NK1L repertoire. 
Indeed, a definite, though modest, increase in the frequency 
of expression of additional MHC-specific NKRs has been 
observed in NK cells expressing a useless  receptor, suggest- 
ing that at least some of the NK cells that fail to express an 
appropriate NKR might be deleted. 
Clonal Adaptation.  Other  observations,  however,  sug- 
gest  that  cellular  adaptation  rather  than  deletion  may be 
prominent in shaping the NKR. repertoire. For example, it 
has been observed that the surface concentration of Ly49A, 
an  NK1L  for  D a,  is  decreased  twofold  in  Da-expressing 
mice (18). Conversely, many Ly49 isotypes have been shown 
to be upregulated in [32m-deficient mice, possibly to make 
up  for  the  decreased  concentration  of MHC  molecules 
(19).  It is not clear yet whether these modulations merely 
result from receptor engagement, or whether they might re- 
flect a process of receptor calibration (14).  In such a calibra- 
tion model, NK cells would each increase or decrease their 
level of receptors so as to be unresponsive to cells express- 
ing the baseline concentration of existing MHC class I alle- 
les while being maximally sensitive to MHC downmodula- 
tion. It is noteworthy in the context of this hypothesis that 
several potentially autoreactive T  cell subsets, some of which 
also  express NK receptors, have been reported to  express 
decreased levels of TCR or CD8 coreceptor (20-23). 
Another form of cellular adaptation is clonal inactivation. 
In this issue of The Journal of Experimental Medicine, Johans- 
son et al.  examined NK cell tolerance in  transgenic  mice 
with a mosaic expression of the D a. Mosaic expression of a 
transgene is thought to occur as a result of stochastic gene 
inactivation linked to particular sites of integration, and re- 
sults  in a proportion of cells that do not express the trans- 
gene.  In this case, the cells  do not express an MHC allele 
expressed by other cells in the mouse. A  somewhat similar 
situation may be achieved in hemopoietic radiation chimeras 
reconstituted with a mixture of ~2m-sufl~cient and -defi- 
cient fetal liver cells  (24).  In both cases, NK cells appeared 
to be tolerant of the cells that do not express MHC class I. 
However, when Johansson et al.  isolated Dd-positive NK 
cells from the Da-negative NK cells and cultured them for 
24 h, the cells  completely recovered the ability to kill D a- 
negative targets. 
This striking result argues that NK cells capable of reac- 
tivity to the Da-negative targets had not been deleted in the 
mosaic mouse.  Several possibilities may account  for their 
extremely rapid functional recovery. One possibility is that 
the autoreactive NK cells were only tolerant in appearance; 
when  the  mosaic populations  were  tested  against MHC- 
negative targets, their killing ability was hidden because of 
the competition by the MHC-negative cells in the mosaic. 
Thus, the killing activity was revealed a~er removal of these 
MHC-negative cells.  This seems rather unlikely, since the 
mosaic mice appeared to have stable proportions of MHC- 
positive and -negative cells. Moreover, in the case of mixed 
fetal liver chimeras, the proportion of [32m-positive and -neg- 
ative hemopoietic cells  roughly corresponded to that used 
for reconstitution,  arguing  against  a  continuous  attack  of 
the latter by NK cells.  Another possibility is that the  NK 
cells  were  'anergic' or desensitized  to  the  absence of D a, 
and  could  very  promptly  recover  in  the  absence  of the 
tolerogen.  Finally,  existing functional NK cells  may have 
adapted  to  their  new  environment  by recalibrating  their 
various NK receptors to  match the  new MHC  levels. As 
discussed  above, the latter possibility might be difficult to 
test at present because subtle adjustments of the expression 
of several MHC-specific receptors might be involved. 
Although  more refined genetic  approaches are on their 
way to further probe the rules of selection and adaptation 
in NK cells,  the results reported by Johansson et al. already 
suggest that NK cells may have solved the problem of toler- 
ance in a unique fashion.  Future studies  in this field may also 
illuminate  the  intriguing  observation  that  MHC-specific 
NKRs are also  expressed by other cell lineages, including 
some T  cell subsets (21,  25, 26) and mast cells (27). 
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